# EDGAR Filing Document

**Accession Number:** 0000849395
**File Stem:** 0001193125-26-223974
**Filing Date:** 2026-5
**Character Count:** 9191
**Document Hash:** a3d58bec0727866f25f3acc33699e9ba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-223974.hdr.sgml**: 20260514

**ACCESSION NUMBER**: 0001193125-26-223974

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260512

**FILED AS OF DATE**: 20260514

**DATE AS OF CHANGE**: 20260514

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bryan Aylwyn
- **CENTRAL INDEX KEY:** 0002134917

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32846
- **FILM NUMBER:** 26978697

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** C/O CRH PUBLIC LIMITED COMPANY
- **STREET 2:** CRH PLC STONEMASON'S WAY
- **CITY:** RATHFARNHAM
- **NON US STATE TERRITORY:** DUBLIN
- **PROVINCE COUNTRY:** L2
- **ZIP:** D16 KH51
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CRH PUBLIC LTD CO
- **CENTRAL INDEX KEY:** 0000849395
- **STANDARD INDUSTRIAL CLASSIFICATION:** CEMENT, HYDRAULIC [3241]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** STONEMASON'S WAY, RATHFARNHAM
- **CITY:** DUBLIN 16
- **STATE:** L2
- **ZIP:** D16 KH51
- **BUSINESS PHONE:** 353 1 404 1000

**MAIL ADDRESS:**
- **STREET 1:** STONEMASON'S WAY, RATHFARNHAM
- **CITY:** DUBLIN 16
- **STATE:** L2
- **ZIP:** D16 KH51

## Ex-24

**POWER OF ATTORNEY FOR SECTION 16 & RULE 144 REPORTING** 

**OBLIGATIONS**

Know all by these presents, that the undersigned hereby constitutes and appoints each of the Company Secretary, Neil Colgan, the Assistant Company Secretary, Diarmuid Enright, the Senior Manager, Office of the Company Secretary, Nicola Connolly, and the Deputy General Counsel – Securities, Cot Eversole of CRH public limited company (the "Company") as the undersigned's true and lawful attorney-in-fact to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. execute for and on behalf of the undersigned, in the undersigned's capacity as an officer or director or both of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, Form ID and any Form 144 under the Securities Act of 1933, as amended, and, in each case, any amendments thereto;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, 5, 144 or ID, complete and execute any amendments thereto, and timely file such form with the Securities and Exchange Commission and any securities exchange or similar authority;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to each of the undersigned's attorneys-in-fact appointed by this Power of Attorney and approves and ratifies any such release of information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. take any other action in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by or for, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such information and disclosure as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary, desirable or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request and on the behalf of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with, or any liability for the failure to comply with, any provision of Section 16 of the Exchange Act.

------

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5, 144 and ID with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of <u>May 12, 2026.</u>

Signed and acknowledged:

---

| |
|:---|
| /s/ Aylwyn Bryan |
| Signature |

---

<u>Aylwyn Bryan</u>   <br> Printed Name

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bryan Aylwyn<br><sub>(Last) (First) (Middle)</sub><br>C/O CRH PLC<br>STONEMASON'S WAY<br><sub>(Street)</sub><br>RATHFARNHAM DUBLIN, IRELAND D16 KH51<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>CRH PUBLIC LTD CO [ CRH ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-05-12 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Financial Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 16286 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Share Units | <sup>(1)</sup> | <sup>(1)</sup> | Ordinary Shares | 6678 | <sup>(1)</sup> | D |  |

---

### Footnotes:

(1) Reflects time-based conditional awards, as defined in the CRH plc Equity Incentive Plan (the "EIP"), granted in May 2025 (3,459) and February 2026 (3,219).  1/3 of each award will vest on the grant anniversary over the three years following the respective grant date.  In accordance with the EIP, dividend equivalents will apply to the awards and will be reported at the time of vesting.  Each restricted share unit represents the rights to receive one Ordinary Share of the Issuer.

**Remarks:**
The Reporting Person began his role as the Registrant's Chief Financial Officer, effective May 12, 2026.
Exhibit 24 - Power of Attorney

**Signature:** /s/ Cot Eversole, attorney-in-fact for Aylwyn Bryan  
**Date:** 2026-05-14

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**